Trial Profile
A Double-Blind, Randomized, Placebo- and Active-Controlled Crossover Study to Evaluate the Abuse Potential of Istradefylline in Recreational Drug Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Istradefylline (Primary) ; Phentermine
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 17 Aug 2016 Status changed from active, no longer recruiting to completed.
- 17 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 19 Jan 2016 According to ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.